Huaqiang Zhou
13PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Sep 26, 2024
Surufatinib plus toripalimab combined with etoposide and cisplatin as first-line treatment in advanced small-cell lung cancer patients: a phase Ib/II trial.Yaxiong Zhang, Yan Huang, Yunpeng Yang
|Aug 12, 2024
Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial.Hua-Qiang Zhou, Ya-Xiong Zhang, Gang Chen
|Mar 06, 2024
Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma.Yuxiang Ma, Huaqiang Zhou, Fan Luo
|Nov 12, 2021
Incidence and risk factors of second primary cancer after the initial primary human papillomavirus related neoplasms.Jiayi Shen, Huaqiang Zhou, Jiaqing Liu
|Feb 24, 2021
Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer.Wenfeng Fang, Haoxuan Jin, Huaqiang Zhou
|Mar 21, 2020
PBRM1 mutation and preliminary response to immune checkpoint blockade treatment in non-small cell lung cancer.Huaqiang Zhou, Jiaqing Liu, Yaxiong Zhang
Pageof 3
Frequent Collaborators
3 joint publications
Li Zhang
2 joint publications
Yaxiong Zhang
2 joint publications
Wei Xian
2 joint publications
Gang Chen
2 joint publications
Hongyun Zhao
1 joint publications
Xiaoyue Wei
1 joint publications
Shaowei Gao
1 joint publications
Shaodong Hong
1 joint publications
Xue Wu
1 joint publications
Dongbing Liu
